Cancer & Pharmaceutical Sciences

Medicine and Dentistry

1. Patient 100%
2. Therapeutic Procedure 48%
3. Breast Cancer 34%
4. Malignant Neoplasm 32%
5. Woman 26%
6. Analysis 25%
7. Disease 18%
8. Diagnosis 18%
9. Neoplasm 17%
10. Prostate Cancer 14%
11. Age 14%
12. Screening 13%
13. Cells 13%
14. Man 12%
15. Hospital 11%
16. Association 11%
17. Symptom 11%
18. Follow up 11%
19. Cohort Analysis 11%
20. Systematic Review 10%
21. Symptomatic Treatment 10%
22. Health 9%
23. Breast 9%
24. Adult 8%
25. Drug 8%
26. Child 8%
27. Sickle-Cell Disease 7%
28. Experience 7%
29. Therapeutics 7%
30. Hazard Ratio 7%
31. Wart Virus 7%
32. Mortality 7%
33. Incidence 7%
34. Randomized Controlled Trial 6%
35. Myelodysplastic Syndrome 6%
36. COVID-19 6%
37. Gene 6%
38. Marker 6%
39. Prognosis 6%
40. Radiation Therapy 6%
41. In Vitro 5%
42. Cervical Screening 5%
43. T Cell 5%
44. Lung 5%
45. Biological Marker 5%
46. Lung Cancer 5%
47. Cervical Cancer 5%
48. Esophageal Cancer 5%
49. Metastatic Carcinoma 5%
50. Meta-Analysis 5%
51. Transplantation 5%
52. Health Care Cost 5%
53. Drug Therapy 5%